Douglas Lane & Associates’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $41.1M | Buy |
477,780
+2,690
| +0.6% | +$236K | 0.56% | 73 |
|
|
2026
Q1 | $43M | Buy |
475,090
+14,912
| +3% | +$1.37M | 0.62% | 68 |
|
|
2025
Q4 | $41.4M | Buy |
460,178
+28,818
| +7% | +$2.73M | 0.57% | 77 |
|
|
2025
Q3 | $42.5M | Buy |
431,360
+29,011
| +7% | +$2.87M | 0.59% | 72 |
|
|
2025
Q2 | $36.7M | Sell |
402,349
-20,954
| -5% | -$2.03M | 0.53% | 73 |
|
|
2025
Q1 | $47.9M | Buy |
423,303
+21,095
| +5% | +$2.26M | 0.71% | 57 |
|
|
2024
Q4 | $42.5M | Sell |
402,208
-14,085
| -3% | -$1.51M | 0.6% | 71 |
|
|
2024
Q3 | $44.9M | Sell |
416,293
-36,705
| -8% | -$4.01M | 0.62% | 66 |
|
|
2024
Q2 | $49.2M | Sell |
452,998
-62,355
| -12% | -$7.35M | 0.7% | 55 |
|
|
2024
Q1 | $68M | Sell |
515,353
-34,703
| -6% | -$4.33M | 0.96% | 40 |
|
|
2023
Q4 | $66.9M | Sell |
550,056
-53,961
| -9% | -$6.02M | 1.03% | 37 |
|
|
2023
Q3 | $67.8M | Sell |
604,017
-22,027
| -4% | -$2.8M | 1.14% | 38 |
|
|
2023
Q2 | $91.2M | Sell |
626,044
-15,685
| -2% | -$2.13M | 1.47% | 16 |
|
|
2023
Q1 | $82.9M | Sell |
641,729
-8,932
| -1% | -$1.12M | 1.38% | 20 |
|
|
2022
Q4 | $83M | Sell |
650,661
-319
| -0% | -$37K | 1.39% | 22 |
|
|
2022
Q3 | $68.1M | Buy |
650,980
+11,930
| +2% | +$1.31M | 1.26% | 30 |
|
|
2022
Q2 | $67.1M | Buy |
639,050
+29,366
| +5% | +$3.48M | 1.14% | 36 |
|
|
2022
Q1 | $78M | Buy |
609,684
+41,230
| +7% | +$4.97M | 1.1% | 34 |
|
|
2021
Q4 | $70.1M | Buy |
568,454
+54,699
| +11% | +$7.16M | 0.93% | 38 |
|
|
2021
Q3 | $73M | Buy |
513,755
+28,868
| +6% | +$4.25M | 1.04% | 31 |
|
|
2021
Q2 | $75.7M | Buy |
484,887
+6,715
| +1% | +$1.09M | 1.06% | 35 |
|
|
2021
Q1 | $74.3M | Buy |
478,172
+5,832
| +1% | +$903K | 1.15% | 32 |
|
|
2020
Q4 | $70.7M | Sell |
472,340
-435
| -0.1% | -$61.4K | 1.18% | 33 |
|
|
2020
Q3 | $62.5M | Buy |
472,775
+26,988
| +6% | +$3.53M | 1.24% | 28 |
|
|
2020
Q2 | $51.7M | Buy |
445,787
+22,432
| +5% | +$2.58M | 1.11% | 39 |
|
|
2020
Q1 | $41.5M | Buy |
423,355
+24,993
| +6% | +$3.28M | 1.09% | 37 |
|
|
2019
Q4 | $57.9M | Buy |
398,362
+35,745
| +10% | +$4.93M | 1.08% | 40 |
|
|
2019
Q3 | $48.3M | Buy |
362,617
+81,737
| +29% | +$10.6M | 0.96% | 47 |
|
|
2019
Q2 | $32.1M | Buy |
280,880
+228,162
| +433% | +$26.7M | 0.63% | 62 |
|
|
2019
Q1 | $6.54M | Buy |
+52,718
| New | +$5.99M | 0.14% | 106 |
|
|
2016
Q3 | – | Sell |
-4,057
| Closed | -$474K | – | 218 |
|
|
2016
Q2 | $474K | Sell |
4,057
-124
| -3% | -$14K | 0.01% | 174 |
|
|
2016
Q1 | $433K | Buy |
+4,181
| New | +$404K | 0.01% | 179 |
|
Other funds holding ZBH
Douglas Lane & Associates's ZBH Position: Q2 2026 in Review
Douglas Lane & Associates increased its Zimmer Biomet (ZBH) stake by 0.57% in Q2 2026, buying an estimated $236K and bringing the position to 477,780 shares worth $41.1M. The position accounts for 0.56% of the portfolio, ranked #73.
Douglas Lane & Associates first reported a position in ZBH in Q1 2016 and has held it in 32 quarters since. The position peaked at $91.2M in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Douglas Lane & Associates held 477,780 shares of Zimmer Biomet worth $41.1M as of Q2 2026.
- Douglas Lane & Associates bought 2,690 Zimmer Biomet shares in Q2 2026, an estimated $236K.
- Zimmer Biomet made up 0.56% of Douglas Lane & Associates's portfolio in Q2 2026, its #73 holding.
- Douglas Lane & Associates first reported a position in Zimmer Biomet in Q1 2016 and has held it in 32 quarters since.
- Douglas Lane & Associates's Zimmer Biomet position peaked at $91.2M in Q2 2023.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.